E.E. Geduld’s Viridian Therapeutics VRDN Stock Holding History

E.E. Geduld’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-44	Closed	-$71K	–	275
2014 Q2	$71K	Buy	+44	New	+$77.7K	0.04%	242

Other funds holding VRDN

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

E.E. Geduld's VRDN Position: Q3 2014 in Review

E.E. Geduld sold out of Viridian Therapeutics (VRDN) in Q3 2014, closing a stake of 44 shares — an estimated $71K sold.

E.E. Geduld first reported a position in VRDN in Q2 2014 and held it in 1 quarter. The position peaked at $71K in Q2 2014. 5 funds tracked by Wall St. Rank hold VRDN as of Q3 2014.

E.E. Geduld reported no remaining Viridian Therapeutics position as of Q3 2014 after selling out during the quarter.
E.E. Geduld sold 44 Viridian Therapeutics shares in Q3 2014, an estimated $71K.
E.E. Geduld first reported a position in Viridian Therapeutics in Q2 2014 and held it in 1 quarter.
E.E. Geduld's Viridian Therapeutics position peaked at $71K in Q2 2014.
5 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2014.

Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.